期刊文献+

8例胸膜上皮型恶性间皮瘤临床病理观察 被引量:1

Pleural epithelial malignant mesothelioma: Clinicopathologic observation of 8 cases
下载PDF
导出
摘要 目的 探讨胸膜上皮型恶性间皮瘤的临床病理特征、诊断及鉴别诊断.方法 收集胸膜活检标本,分析8例胸膜上皮型恶性间皮瘤的临床资料、病理特点及免疫组化标记.结果 胸膜上皮型恶性间皮瘤好发于中老年人,平均年龄57.75岁,临床表现主要为胸水、胸闷、气短、咳嗽等,影像学CT示胸膜不均匀增厚.镜下形态:瘤细胞呈上皮样,因其分化程度的不同,在组织结构上有很大的差异,表现为腺管状、乳头状或实性排列.免疫组化显示AE1/AE3(8/8)、Vimentin(8/8)、Calretinin(CR)(8/8)、CK5/6(7/8)、CK7(4/8)为阳性,TTF-1全部阴性.结论 胸膜上皮型恶性间皮瘤的确诊需结合临床特征、影像学检查、病理形态及免疫表型,且需与胸膜原发或转移的其他肿瘤相鉴别. Objective To investigate the clinicopathologic features,diagnosis and differential diagnosis of pleural epithelial malignant mesothelioma (PEMM).Method Based on pleural biopsy specimens collected,clinical data,pathological features,and immunohistochemical markers in 8 patients with PEMM were analyzed.Results PEMM occurred frequently in the middle-aged and the elderly,with the average age of 57.75 years old.The major clinical manifestations included pleural effusion,chest pain,breathlessness,cough.Irregular thickening of pleura was shown by CT.With different degrees of differentiation,tumor cells differed in histological structure,showing glandular,papillary or solid arrangement.Immunohistochemically,AE1/AE3 (8/8),Vimentin (8/8),Calretinin (8/8),CK5/6 (7/8),CK7 (4/8) exhibited positive findings,while TTF-1 in all cases exhibited negative findings.Conclusions The accurate diagnosis of PEMM relies on clinical features,imaging examination,pathological morphology,and immunophenotyping tests.And it needs to be distinguished from pleural primary or metastatic tumors.
出处 《国际医药卫生导报》 2016年第13期1888-1890,共3页 International Medicine and Health Guidance News
关键词 胸膜恶性间皮瘤 上皮型 免疫组织化学 诊断 Pleural malignant mesothelioma Epithelial Immunohistochemistry Diagnosis Pleural malignant mesothelioma Epithelial Immunohistochemistry Diagnosis
  • 相关文献

参考文献10

二级参考文献30

  • 1邓明佳,沈丽达.恶性胸膜间皮瘤15例临床分析[J].现代肿瘤医学,2006,14(9):1085-1087. 被引量:1
  • 2Yaziji H,Battifora H,Barry T,黄文斌(摘译).12种抗体对区分上皮样间皮瘤和腺癌的评价:3种抗体具有最大的敏感性和特异性[J].临床与实验病理学杂志,2006,22(5):574-574. 被引量:14
  • 3Ordonez N G,饶秋(摘译),潘敏鸿(摘译),周晓军(审校).免疫组化在鉴别上皮样间皮瘤和肺鳞状细胞癌中的比较研究[J].临床与实验病理学杂志,2006,22(6):741-741. 被引量:14
  • 4Zucali PA, De Vincenzo F, Simonelli M, et al. Future develop- ments in the management of malignant pleural mesothelioma [ J ]. Expert Rev Anticancer Ther, 2009,9(4) :453-467.
  • 5Chen SE, Pace MB. Malignant pleural mesothelioma [ J ]. Am J Health Syst Pharm, 2012,69 (5) :377-385.
  • 6Oken MM, Creech RH, Tormey DC, et al. Toxicity and Response Criteria of the Eastern Cooperative Oncology Group[ J]. Am J Clin Oncol, 1982,5:649-655.
  • 7Kent M, Rice D, Flores R. Diagnosis, staging, and surgical treat- ment of malignant pleural mesothelioma[J]. Curr Treat Options On- col,2008,9 ( 2-3 ) : 158-170.
  • 8Robinson BW, Lake RA. Advances in malignant mesothelioma[ J]. N Engl J Med, 2005,353:1591-1603.
  • 9Campbell NP, Kindler HL. Update on Malignant Pleural Mesothelio- ma[J]. Semin Respir Crit Care Med,2011,32( 1 ) :102-110.
  • 10Robinson BW, Musk AW, Lake RA. Malignant mesothelioma[J]. Lancet, 2005,366:397-408.

共引文献46

同被引文献4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部